SIREN : 829224765
BIO SENS is a French company founded 9 years ago, specialized in the sector Commerce d'alimentation générale. Based in SAINT-CLEMENT (89100), this company of category PME shows in 2024 a revenue of 1.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1 833 290 € | 1 825 631 € | 1 738 516 € | N/C | N/C | N/C |
| Net income | 27 930 € | 25 594 € | 34 428 € | 53 124 € | 149 319 € | 47 830 € |
| EBITDA | 65 053 € | 63 116 € | 104 414 € | N/C | N/C | N/C |
| Net margin | 1.5% | 1.4% | 2.0% | N/C | N/C | N/C |
In 2024, BIO SENS achieves revenue of 1.8 M€. Revenue is growing positively over 6 years (CAGR: +2.7%). Vs 2023: +0%. After deducting consumption (1.4 M€), gross margin stands at 473 k€, i.e. a rate of 26%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 65 k€, representing 3.5% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 28 k€, i.e. 1.5% of revenue. This profit can be retained or distributed to shareholders.
1 833 290 €
472 967 €
65 053 €
25 331 €
27 930 €
3.5%
The debt ratio (= Financial debt / Equity x 100) stands at 38%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.8 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 3.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
37.711%
41.404%
3.18%
0.78
28.8%
In 2024, the debt ratio of BIO SENS (37.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of BIO SENS (41.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of BIO SENS (0.78) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 134.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 2.7x. Financial charges are adequately covered by operations.
134.34
2.662
In 2024, the liquidity ratio of BIO SENS (134.34) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of BIO SENS (2.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 2 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 43 days. Excellent situation: suppliers finance 41 days of the operating cycle (retail model). Inventory turnover is 45 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 60 days of revenue, i.e. 303 k€ to permanently finance.
303 446 €
2 j
43 j
45 j
60 j
Based on 551 transactions of similar company sales in 2024, the value of BIO SENS is estimated at 312 776 € (range 137 028€ - 633 282€). With an EBITDA of 65 053€, the sector multiple of 4.7x is applied. The price/revenue ratio is 0.23x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 551 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIO SENS with other companies in the same sector:
Voir toutes les statistiques du secteur Commerce d'alimentation générale
The revenue of BIO SENS in 2024 is 1.8 M€.
Yes, BIO SENS generated a net profit of 28 k€ in 2024.
The headquarters of BIO SENS is located in SAINT-CLEMENT (89100), in the department Yonne.
The tax return of BIO SENS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIO SENS operates in the sector Commerce d'alimentation générale (NAF code 47.11B). See the 'Sector positioning' section above to compare the company with its competitors.